Mode
Text Size
Log in / Sign up
N/A N=2,295

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Herpes Simplex

Enrolled (actual)
2,295
Serious AEs
Results posted
Jun 2020
Primary outcome: Primary: Number of Participants Positive and Negative for HSV-1 by SA201 HSV-1/2 PCR Test — 281; 54; 9; 1237 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Vela Sentosa SA HSV1/2 Qualitative PCR Test (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
Vela Diagnostics
Primary completion
Apr 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Positive and Negative for HSV-1 by SA201 HSV-1/2 PCR Test
281; 54; 9; 1237
PRIMARY
Number of Participants Positive and Negative for HSV-2 by SA201 HSV-1/2 PCR Test
391; 147; 6; 1434

Summary

The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.

Eligibility Criteria

Inclusion Criteria

  • Sample was taken from a lesion from an internal or external oral or genital site.
  • Sample was submitted to a clinical laboratory for the purpose of testing for the presence of HSV1 or HSV2.
  • The following information about the patient from which the sample was taken is available: presumptive diagnosis or signs and symptoms causing assay requisition; site of lesion; age at time of sample collection or date of birth, and sex.
  • Sample was collected in universal viral transport media, using a plastic shaft swab made of either polyester, cotton, rayon or Dacron.
  • There is sufficient residual sample to perform both test and reference assays.

Exclusion Criteria

  • Sample leaked during shipment or storage prior to assay.
  • Sample has undergone more than 1 freeze-thaw cycle before testing;
  • Sample eluent is not clear after centrifugation (refer to section 6.3.1).
  • Sample ID is missing or ambiguous.
  • Sample is collected using alginate calcium swab.
  • Sample handling and storage requirement in section 5.4 not followed
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02685956). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search